China Medical GatewayLoading your healthcare gateway…

Heart Valve Disease in China

Overview

Heart valve disease means one or more of the four valves — aortic, mitral, tricuspid or pulmonary — fail to open fully (stenosis) or close properly (regurgitation), placing progressive strain on the heart. Timely repair or replacement prevents irreversible muscle damage and heart failure.

Chinese structural heart programs are among the world’s highest-volume TAVR centers, with extensive experience in transcatheter and robotic approaches that avoid open-chest surgery for patients previously considered inoperable.

Symptoms & Signs

Breathlessness on exertion, progressing to breathlessness at rest and orthopnea

Fatigue, palpitations and reduced exercise capacity

Ankle swelling and weight gain from fluid retention in advanced disease

Fainting or near-fainting episodes, characteristically in severe aortic stenosis

Often first detected as a heart murmur on routine examination before symptoms develop

Complications of untreated disease: atrial fibrillation, pulmonary hypertension and heart failure

Diagnosis

Transthoracic echocardiography — the primary tool defining valve anatomy, severity and heart function

Transesophageal and 3D echocardiography for detailed valve anatomy and procedural planning

ECG-gated cardiac CT sizing valves and access vessels for transcatheter procedures

Cardiac catheterization and coronary angiography to exclude coexisting CAD before surgery

Heart-team assessment combining cardiologists, surgeons and imaging specialists to choose the optimal approach

Exercise testing to unmask symptoms in seemingly asymptomatic severe stenosis

Treatment Options

Valve repair — the preferred approach for suitable mitral and tricuspid disease, preserving native tissue

Valve replacement with mechanical valves (lifelong durability) or bioprosthetic tissue valves (no long-term anticoagulation)

Minimally invasive and robotic surgical approaches avoiding full sternotomy, with faster recovery

TAVR/TAVI transcatheter aortic valve replacement for aortic stenosis, including in frail and high-risk patients

Transcatheter edge-to-edge repair (MitraClip-class) for mitral regurgitation in patients unfit for surgery

Anticoagulation and rhythm management programs for patients in atrial fibrillation

Advanced Technologies & Novel Drug

Latest-generation TAVR valves with lower delivery profiles and cerebral embolic protection

MitraClip-class transcatheter edge-to-edge repair systems

3D echocardiography and CT fusion imaging planning software

Robotic and rapid-deployment surgical valve platforms shortening operative time

Novel oral anticoagulants and heart-failure medications (ARNI, SGLT2 inhibitors) optimizing medical therapy around procedures

Hospital & Specialist

Return to Home